Showing results (171-180 of 208) with videos related to
Sort By:
Pageof 21
European Heart Journal. Cardiovascular Pharmacotherapy|January 26, 2018
Circadian variation of ticagrelor-induced platelet inhibition in healthy adultyStephane Fournier, Florine Guenat, Anne Fournier, et al.British Journal of Haematology|May 6, 2021
A universal anti-Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validationGuido Willekens, Jan-Dirk Studt, Adriana Mendez, et al.JHEP Reports : Innovation in Hepatology|August 5, 2024
Direct oral anticoagulants in cirrhosis: Rationale and current evidenceCindy Pereira Portela, Lucas A Gautier, Maxime G Zermatten, et al.Life (Basel, Switzerland)|July 27, 2022
Prothrombinase-Induced Clotting Time to Measure Drug Concentrations of Rivaroxaban, Apixaban, and Edoxaban in Clinical Practice: A Cross-Sectional StudyVepusha Sathanantham, Lorenzo Alberio, Cédric Bovet, et al.Thrombosis Journal|March 19, 2013
Variability between laboratories performing coagulation tests with identical platforms: a nationwide evaluation studyMichael Nagler, Lucas M Bachmann, Lorenzo Alberio, et al.Thrombosis and Haemostasis|December 5, 2017
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate Oral Liquid Formulation in Infants with Venous ThromboembolismJacqueline M L Halton, Anne-Caroline Picard, Ruth Harper, et al.Hamostaseologie|December 14, 2022
[Gene therapy of Hemophilia: Recommendations from the German, Austrian, and Swiss Society for Thrombosis and Haemostasis Research (GTH)]Wolfgang Miesbach, Johannes Oldenburg, Robert Klamroth, et al.Journal of Thrombosis and Haemostasis : JTH|November 11, 2020
Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19-related illnessNeil A Goldenberg, Anthony Sochet, Manuela Albisetti, et al.Journal of Thrombosis and Haemostasis : JTH|January 11, 2025
Systematic analysis of the design, methodology, and patient population characteristics of the pediatric direct oral anticoagulant trials of venous thromboembolism treatmentMarisol Betensky, Manuela Albisetti, Tina Biss, et al.Hamostaseologie|February 19, 2025
Guidance-Based Appropriateness of Hemostasis Testing in the Acute SettingLuigi Devis, Deepa J Arachchillage, Michael Hardy, et al.Pageof 21